Mostrando 2 resultados de: 2
Filtros aplicados
Subtipo de publicación
Article(2)
Área temáticas
Enfermedades(2)
Área de conocimiento
Cáncer(2)
Origen
scopus(2)
Nimotuzumab plus radiotherapy for unresectable squamous-cell carcinoma of the head and neck
ArticleAbstract: The prognosis of patients with advanced head and neck cancer remain dismal. For this tumor type, elePalabras claves:Epidermal growth factor receptor, immunotherapy, Monoclonal antibody, nimotuzumab, Squamous cell carcinoma of the head and neck, Targeted therapyAutores:Alert J., Bahi R.D.C., Bárbara Wilkinson, Bilbao M.A., Carmen Elena Viada, De Armas E.L., Frómeta M., Galainena J.J., Gracias E., Iznaga N., Leonard I., Luaces P.L.o., Muchuli C.R., Mulén B., Mullens V., Pérez K., Pineda I., Rivero T.C., Rodríguez E., Rodríguez M.O., Tania Crombet, Torres O., Vinageras E.N.Fuentes:scopusPhase II randomized controlled trial of an epidermal growth factor vaccine in advanced non-small-cell lung cancer
ArticleAbstract: Purpose: We show the result of a randomized phase II clinical trial with an epidermal growth factorPalabras claves:Autores:Abreu D.A., Bravo I., Brooks S.A., Carmen Elena Viada, Carrillo C.d.C., Dávila A.L., De La Torre A.V., Del Pino M.M., Dueñas M.G., Ferrer M.C., Marinello G.G., Ramos T.C., Rives R., Rodríguez M.O., Verdecia B.G., Vinageras E.N.Fuentes:scopus